WIKA strengthens management team with Axel Schwerdtfeger

Process Solutions company division under new leadership

28-Oct-2025
WIKA Alexander Wiegand SE & Co. KG

Axel Schwerdtfeger

With Axel Schwerdtfeger, the WIKA Group has recruited an experienced leader and expert from the industry. He has been appointed as Executive Vice President of the Process Solutions company division, effective 1 October. As a member of the Management Board, he will also contribute significantly to shaping and executing the global business strategy of the measurement technology manufacturer.

Axel Schwerdtfeger will focus on the strategic development of the company division’s product and service portfolio, including that of its affiliated subsidiaries. His priorities also include delivering innovative solutions with high added value for customers and driving continuous optimisation of business processes.

“Global megatrends such as digitalisation and decarbonisation are fundamentally reshaping business requirements – while simultaneously opening up vast opportunities for innovation and growth,” says Axel Schwerdtfeger. “With our broad technology portfolio, international orientation and strong internal collaboration, we at WIKA are ideally positioned to actively shape this transformation. I look forward to working with our customers to develop forward-looking solutions that deliver genuine added value.”

Prior to joining WIKA, Axel Schwerdtfeger served as CTO and member of the Executive Board at HAWE Hydraulik SE, a Munich-based manufacturer of mechatronic and hydraulic components and systems. Over 20 years, he held various roles at the international family-owned company with global subsidiaries, including a two-year tenure as COO of its branch in Shanghai, China. He holds a degree in industrial engineering.

“Axel Schwerdtfeger possesses a deep understanding of the industries and markets we serve,” says Alexander Wiegand, Chairman and CEO of WIKA. “He is also a determined leader. He will play a pivotal role in positioning our Process Solutions company division so that it is ideally equipped to meet the challenges of today and tomorrow.”

Other news from the department people

Most read news

More news from our other portals

Last viewed contents

Otto Warburg Medal 2026 awarded to Maya Schuldiner

Otto Warburg Medal 2026 awarded to Maya Schuldiner

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research

Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

First-of-its-kind vaccine expands malaria protection for pregnant women - Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years

First-of-its-kind vaccine expands malaria protection for pregnant women - Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years

Bayer awards incubator opportunity to Genvor - Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies

Bayer awards incubator opportunity to Genvor - Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies

Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration - Strategic academic-industry alliance aims to build robust Research & Development talent pipeline

Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration - Strategic academic-industry alliance aims to build robust Research & Development talent pipeline

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina - Facility designed to advance the next generation of imaging systems

Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina - Facility designed to advance the next generation of imaging systems

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim - Novel targets in oncology

QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim - Novel targets in oncology

Giles introduces AI agent to accelerate healthcare and life science research - AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles

Giles introduces AI agent to accelerate healthcare and life science research - AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles